New Delhi: The Drug Controller General of India (DCGI) has approved the emergency use of DRDO’s anti-COVID-19 therapeutic oral drug 2-deoxy-D-glucose (2-DG) as adjunct therapy in moderate to severe COVID-19 patients. On…
New Delhi: The Drug Controller General of India (DCGI) has approved the emergency use of DRDO’s anti-COVID-19 therapeutic oral drug 2-deoxy-D-glucose (2-DG) as adjunct therapy in moderate to severe COVID-19 patients.
On May 1, the DCGI granted permission for ‘Emergency Use’ of this drug. Being a generic molecule and analogue of glucose, it can be easily produced and made available in plenty in the country.
Karnataka Housing Board earmarks 1,900 acres near Bommanahalli in Yelwal hobli Submits proposal to State Govt. seeking land notification Mysuru: Amidst the ongoing Bidadi Township row where the farmers have been protesting…
Mysuru: Maintaining that Mysuru Development Authority (MDA) has been left orphaned by the Government with the non-appointment of a regular Commissioner, BJP MLC Raghu Kautilya alleged that the MDA has been virtually…
Mysuru: The State Government should name Suttur Mutt Seer Sri Shivarathri Deshikendra Swamiji to inaugurate Dasara-2026 atop Chamundi Hill on Oct. 11, said BJP MLC Raghu Kautilya. Addressing a press meet at…
